In colon cancer cells, TTP also promotes the downregulation of PTGS2, a potent activator of prostaglandin E2 biosynthesis, which not only promotes cancer cell proliferation, but also impairs T cell activation, thus favoring immune escape [112,113,114]. Here, ZFP36 is linked to cancer.